SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINE
- 31 May 1987
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 329 (8545) , 1277-1281
- https://doi.org/10.1016/s0140-6736(87)90540-x
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Efficacy of Murine Malaria Sporozoite Vaccines: Implications for Human Vaccine DevelopmentScience, 1987
- Construction of Synthetic Immunogen: Use of New T-Helper Epitope on Malaria Circumsporozoite ProteinScience, 1987
- Immunity to Malaria and Naturally Acquired Antibodies to the Circumsporozoite Protein ofPlasmodium falciparumNew England Journal of Medicine, 1986
- Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine.The Journal of Experimental Medicine, 1986
- Safety and antigenicity studies of a polyvalent meningococcal protein-polysaccharide vaccineAntonie van Leeuwenhoek, 1986
- Immunogenicity of Synthetic Peptides from Circumsporozoite Protein of Plasmodium falciparumScience, 1985
- Expression of Plasmodium falciparum Circumsporozoite Proteins in Escherichia coli for Potential Use in a Human Malaria VaccineScience, 1985
- Structure of the Gene Encoding the Immunodominant Surface Antigen on the Sporozoite of the Human Malaria Parasite Plasmodium falciparumScience, 1984
- Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment.Journal of Clinical Investigation, 1981
- Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.The Journal of Experimental Medicine, 1980